(Q34761883)

4 August 2017

1 reference

title

Mycosis fungoides and Sézary syndrome. (English)

1 reference

4 August 2017

1 reference

3

Elaine S Jaffe

1 reference

4 August 2017

4

Wyndham H Wilson

1 reference

4 August 2017

2

John E Janik

1 reference

4 August 2017

Sam T Hwang

1

1 reference

PubMed ID

18342689

4 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

4 August 2017

1 reference

4 August 2017

371

1 reference

4 August 2017

9616

1 reference

4 August 2017

945-957

1 reference

WHO-EORTC classification for cutaneous lymphomas

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Cutaneous T-Cell Lymphomas: The Sézary Syndrome, Mycosis Fungoides, and Related Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Mycosis fungoides beginning in childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Posttransplant cutaneous lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Mycosis fungoides: a wound care challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Role of histology in providing prognostic information in mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

The histologic spectrum of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Defining early mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Mycosis fungoides in young patients: clinical characteristics and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histolog

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Minimal residual disease in mycosis fungoides follow-up can be assessed by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Clonal T cells in the blood of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

The role of Helicobacter pylori in primary gastric MALT lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

1 reference

7 January 2021

HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Detection of Epstein-Barr virus and HTLV-I in T-cell lymphomas of skin in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

The vast majority of CLA+ T cells are resident in normal skin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Aggressive cutaneous T-cell lymphomas after TNFalpha blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Decreased T-cell receptor excision circles in cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

The many roles of chemokines and chemokine receptors in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Cutting edge: identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Increased CCR4 expression in cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

CCR10 is expressed in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

A novel method for the isolation of skin resident T cells from normal and diseased human skin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Elevated serum CTACK/CCL27 levels in CTCL

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Role of the CC chemokine receptor 9/TECK interaction in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Cutaneous T-cell lymphoma/leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Interferon in the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Anti‐tumor immune responses and tumor regression induced with mimotopes of a tumor‐associated T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Topical corticosteroids for mycosis fungoides. Experience in 79 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Psoriasiform mycosis fungoides with fatal outcome after treatment with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Synergistic Enhancement of Cell-Mediated Immunity by Interleukin-12 Plus Interleukin-2: Basis for Therapy of Cutaneous T Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Serological detection of cutaneous T-cell lymphoma-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Histone deacetylases and cancer: causes and therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Therapeutic potential of Toll-like receptor 9 activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Control of immune homeostasis by naturally arising regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

UVB in the management of early stage mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Induction of human tumor-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960420-1

7 January 2021

10.1016/S0140-6736(08)60420-1

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

18342689